Ligand assay using interference modulation

• US 5,196,350 A
• Filed: 05/29/1991
• Issued: 03/23/1993
• Est. Priority Date: 05/29/1991
• Status: Expired due to Fees

• Current Assignee: Omnigene, Inc.
• Original Assignee: Omnigene, Inc.
• Inventors: Munkholm, Christiane, Backman, Keith C.
• Primary Examiner(s): Nucker, Christine M.
• Assistant Examiner(s): PRESTON, DAVID
• Application Number:
  US07/706,772
• Time in Patent Office: 664 Days
• Field of Search: 435/7.1, 435/7.92, 435/7.93, 435/7.94, 435/7.95, 436/501, 436/518, 436/524
• US Class Current: 436/501
• CPC Class Codes: G01N 21/4788 Diffraction for sizing particles G01N15/0205
• CPC Class Codes: G01N 33/54373 involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
• CPC Class Codes: G01N 33/585 with a particulate label, e.g. coloured latex

Abstract

An optical detection method for detecting specific ligands in an immunoassay is formed by diffracting a beam of light through slits formed in a mask and thererby forming an interference pattern. The diffracted light of one of the slits is distributed by an assay having a ligand which when reacted with anti-ligand changes the optical characteristics of the assay thereby changing the interference pattern in a concentration dependent manner.

Claims

1. A method for determining the presence and/or concentration of one or more analytes in a sample, in which each analyte to be determined is capable of being recognized as a ligand by at least one antiligand, comprising the steps of:

a) providing one or more assay substrate(s), each comprising a transparent surface which is coated with an antiligand capable of binding an analyte;

b) reacting the sample with each provided assay substrate under conditions sufficient to cause each analyte whose presence or concentration is to be determined, if and when present in the sample, to bind to the surface coated with its corresponding antiligand;

c) reacting each surface form step b) with an antiligand specific for the analyte immobilized thereon under conditions sufficient to cause the introduced antiligand to bind to the surface substantially only if and when analyte is bound to the surface;

d) providing an opaque mask containing two or more transparent apertures through which light may be projected to form an interference pattern;

e) determining the interference pattern formed when light is projected through apertures substantially identical to the apertures of the mask provided in step d);

f) positioning each assay substrate so that the surface treated in steps b), and c) covers at least one of the apertures of the mask provided in step d), with the proviso that at least one of the apertures of the mask remains uncovered;

g) determining the interference pattern formed when light is projected through the apertures after the positioning of the surface in step f) and

h) correlating changes in one or more features of the interference patterns of step e) and g) with the presence and/or concentration of an analyte in the sample.

2. A method according to claim 1 wherein the apertures are slits.

3. A method according to claim 1 including further treating each surface form step c) so that at least one optical characteristic of each surface is altered substantially only if, when and where the antiligand introduced in step c) is bound to the surface and wherein said further treatment comprises a chemical reaction resulting in the deposition or localization of optically dense or opaque material on the initially transparent surface.

4. A method according to claim 3 wherein said optically dense or opaque material is formed by the deposition of silver grains at the loci or colloidal gold particles associated with an antiligand-analyte complex.

5. A method according to claim 3 wherein the reaction product formed pursuant to said further treatment is a chromophore or pigment, and the light is selected to be of a wavelength which interacts with that chromophore or pigment.

6. A method according to claim 5 wherein multiple analytes are determined using a single analytical assay surface coated with multiple antiligands corresponding to the multiple analytes by the employment of distinct chromophores, each with a substantially non-overlapping absorption spectrum with respect to other chromophores used, associated with the antiligands introduced in step c) for each analyte to be determined.

7. A method according to claim 3 wherein said optical characteristic is selected form the group comprising scattering, absorption, phase shift, refraction or polarization of the incident light.

8. A method according to claim 1 wherein the antiligand of step c) is conjugated with colloidal gold.

9. A method according to claim 1 wherein the optical characteristic of the surface is altered by the attachment of an item selected from the group comprising bacteria, polymeric particles, and cells.

10. A method according to claim 1 wherein the light is monochromatic.

11. A method according to claim 1 wherein the light is coherent.

12. A method according to claim 1 wherein the number of apertures is two.

13. A method according to claim 1 wherein multiple analytes are simultaneously determined by providing multiple analytical assay surfaces, each specific for a particular analyte, and in step f) positioning each analytical assay surface over one or more apertures.

14. A method according to claim 1 wherein any of the antiligands employed is selected from the group comprising antibodies, antigens, nucleic acids, chemical receptors, cyclodextrins, and ion selective membranes.

15. A method according to claim 1 wherein the correlation in step i) is made by comparison of the change in the assay to changes resulting form separately analyzed reference samples of known composition.

16. A method according to claim 1 wherein the feature(s) used for comparison of the interference patterns is selected form the group comprising visibility, I_max, I_min, and mathematical functions of one or more of visibility, I_max, and I_min.

17. A method according to claim 1 wherein one or more of the apertures is a virtual aperture.

18. A method according to claim 17 wherein the virtual aperture(s) are produced by a device selected from the group comprising Lloyd'"'"'s mirror, Fresnel'"'"'s mirror, Fresnel biprism and Billet'"'"'s slit lens.

19. A method according to claim 1 wherein the assay substrate comprises the assay mask, and the apertures comprise the antiligand coated surface.

20. A method for determining the presence and/or concentration of an analyte in a sample, in which the analyte to be determined is capable of being recognized as a ligand by at lest one antiligand, comprising the steps of:

a) providing an assay substrate, comprising a narrow surface coated with an antiligand capable of binding the analyte, with the proviso that the coated surface of the assay substrate and areas immediately adjacent to the coated surface are substantially transparent prior to the assay procedure;

b) reacting the sample with the assay substrate under conditions sufficient to cause the analyte whose presence or concentration is to be determined, if and when present in the sample to bind to the surface coated with the antiligand;

c) reacting the surface form step b) with an antiligand specific for the analyte immobilized thereon under conditions sufficient to cause the introduced antiligand to bind to the surface substantially only if an when analyte is bound to the surface;

d) providing an opaque mask containing a transparent slit whose width exceeds the width of the antiligand coated surface on the assay substrate, through which light may be projected to form an interference pattern;

e) determining the interference pattern formed when light is projected through a slit substantially identical to the slit of the mask provided in step d);

f) positioning the assay substrate so that its antiligand coated surface lies medially over the center of the slit of the mask provided in step

     3);

g) determining the interference pattern formed when light is projected through the covered slit after the positioning of the surface in steps f); and

h) correlating changes in one or more features of the interference patterns of steps e) and g) with the presence and/or concentration of the analyte in the sample.

21. A method according to claim 20 wherein the assay substrate comprises the opaque mask, and the apertures comprise the antiligand coated surfaces.

22. The method of claim 20 including further treating the surface from step c), so that at least one optical characteristic of the surface is altered substantially only if, when, and where the antiligand introduced in step c) is bound to the surface.